Intra-Lymphatic STI-3031 Using the Sofusa DoseConnect Device for Treatment of In-Transit Melanoma, The Sofusa-2 Study

Clinical trial NCT05393713 · TERMINATED

Trial details

NCT number: NCT05393713
Sponsor: Mayo Clinic
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Clinical Stage III Cutaneous Melanoma AJCC v8 Melanoma Metastatic Melanoma Recurrent Metastatic Melanoma

Start date: 2022-10-17
Primary completion: 2025-02-16
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.